-
-
-
-
-
-
-
Royalty Pharma Agrees to Acquire Royalty Interest in TRELEGY ELLIPTA From Theravance and Innoviva for $1.31 Billion and Potential Milestones of $300 Million
-
-
-
-
-
-
-
Theravance Biopharma (TBPH) to Sell VIBATIV to Cumberland Pharmaceuticals (CPIX)
-
-
-
-
-
-
-
Unusual 11 Mid-Day Movers 06/03: (NFEC) (SARA) (ACFN) Higher; (ENSG) (ZQK) (THRX) Lower
1,168,063 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

